Heart Failure
Feature
What is the psychological cost of performing CPR?
Andrés Snitcofsky, a 40-year-old designer from Buenos Aires, Argentina, heard harrowing cries for help.
From the Journals
Persistent gaps in drug use by patients with type 2 diabetes
Continuous use of glucose-, BP-, and cholesterol-lowering medications by adults with mainly type 2 diabetes declined in 2005-2019. This may...
From the Journals
Accelerated pacing a possible strategy for HFpEF?
A study challenges the dogma of beta-blockers for HF with preserved ejection fraction. For now, the strategy might only be for HFpEF patients...
From the Journals
Longer diabetes duration links with increased heart failure
Prospective data from nearly 24,000 people with diabetes showed that longer diabetes duration significantly linked with an increased heart failure...
From the Journals
Legacy ICDs exposed to MRI still shock, pace as needed
Non–MRI-conditional devices need a few adjustments before imaging but still reliably deliver therapy.
From the Journals
CV deaths jumped in 2020, reflecting pandemic toll
The American Heart Association 2020 Statistical Update offers lessons for addressing structural issues that drive health disparities.
From the Journals
Angioedema risk jumps when switching HF meds
The risk for angioedema rises when switching from an ARB or ACE inhibitor to ARNI, observational data suggest.
From the Journals
Noninvasive liver test may help select asymptomatic candidates for heart failure tests
Heart failure and liver stiffness often coexist due to cardio-hepatic interactions.
From the Journals
More type 2 diabetes deaths from cancer than heart disease
In people with type 2 diabetes, cancer screening should get at least as much attention as CVD prevention.
From the Journals
Medicare policy tweak on LVADs may reduce access to transplant
Advanced heart failure patients who receive an LVAD at a center without a transplant program may be less apt to receive a heart transplant.
From the Journals
Clarity on torsemide vs. furosemide in HF: TRANSFORM-HF published
A new meta-analysis of trials comparing TAVI to surgery for aortic valve stenosis highlights a high rate of potential bias in the trials.